A team of researchers at the University of Minnesota have fully 3D printed an array of light receptors on a hemispherical surface, a significant step toward creating a bionic eye that could someday help blind people see or sighted people see better.
"Bionic eyes are usually thought of as science fiction, but now we are closer than ever using a multimaterial 3D printer," said Michael McAlpine, a co-author of the study and University of Minnesota Benjamin Mayhugh Associate Professor of Mechanical Engineering.
Researchers started with a hemispherical glass dome to show how they could overcome the challenge of printing electronics on a curved surface. Using their custom-built 3D printer, they started with a base ink of silver particles. The dispensed ink stayed in place and dried uniformly instead of running down the curved surface. The researchers then used semiconducting polymer materials to print photodiodes, which convert light into electricity. The entire process takes about an hour.
McAlpine said the most surprising part of the process was the 25 percent efficiency in converting the light into electricity they achieved with the fully 3D-printed semiconductors.
"We have a long way to go to routinely print active electronics reliably, but our 3D-printed semiconductors are now starting to show that they could potentially rival the efficiency of semiconducting devices fabricated in microfabrication facilities," McAlpine said. "Plus, we can easily print a semiconducting device on a curved surface, and they can't."
McAlpine and his team are known for integrating 3D printing, electronics, and biology on a single platform. They received international attention a few years ago for printing a "bionic ear." Since then, they have 3D printed life-like artificial organs for surgical practice, electronic fabric that could serve as "bionic skin," electronics directly on a moving hand, and cells and scaffolds that could help people living with spinal cord injuries regain some function.
McAlpine's drive to create a bionic eye is a little more personal.
"My mother is blind in one eye, and whenever I talk about my work, she says, 'When are you going to print me a bionic eye?'" McAlpine said.
McAlpine says the next steps are to create a prototype with more light receptors that are even more efficient. They'd also like to find a way to print on a soft hemispherical material that can be implanted into a real eye.
McAlpine's research team includes University of Minnesota mechanical engineering graduate student Ruitao Su, postdoctoral researchers Sung Hyun Park, Shuang-Zhuang Guo, Kaiyan Qiu, Daeha Joung, Fanben Meng, and undergraduate student Jaewoo Jeong.
The research was funded by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (Award No. 1DP2EB020537), The Boeing Company, and the Minnesota Discovery, Research, and InnoVation Economy (MnDRIVE) Initiative through the State of Minnesota.
Plan to attend The IMTS 2018 Conferences to gain deeper insights into new manufacturing technologies and ideas!
About the topic
Bringing an IoT solution into an existing facility can be a daunting task – determining what data to collect, how to analyze it, what protocols to use, and how to get multiple platforms to work and communicate together. This presentation will cover the benefits and best practices of data collection, as well as provide some solutions collecting and analyzing data from equipment and machine tools with different platforms or that use different communications protocols.
Meet your presenter
Curt Christensen is the manager of CNC Aftermarket Support at FANUC America Corp.
Amsterdam-based Wright Medical Group NV agreed to acquire Alpharetta, Georgia-based Cartiva Inc., a private orthopedic company focused on thhe treatment of osteoarthritis of the big toe. Wright will acquire 100% of Cartiva's outstanding equity on a fully diluted basis for $435 million in cash.
Marlborough, Massachusetts-based Boston Scientific has agreed to acquire Fremont, California-based medical devices manufacturer Veniti in a deal valued at $160 million – an investor in Veniti since 2016, Boston Scientific has 25% stake in the company, paying $108 million for the remaining stake. Company officials agreed to pay up to $52 million after U.S. FDA approval of the Vici stent system. In June 2018, the company submitted a pre-market approval (PMA) application to the FDA; presently, the system is an investigational device in the U.S.
Carmel, Indiana-based Nanovis completed a $5.5 million funding round brokered by Commenda Securities. Key investors include Elevate Ventures, 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures.
Minneapolis, Minnesota-based Starkey Hearing Technologies' hearing aid with integrated sensors and artificial intelligence – Livio AI – tracks brain and body health, and has a natural user interface with tap control, language translation, and advanced environmental detection. The first device to track physical activity and cognitive health as measured by hearing aid use in social situations, the launch also includes a mobile app – Thrive Hearing; and three wireless accessories – the Starkey Hearing Technologies TV, the Remote, and the Remote Microphone +. With the Remote Micorophone+, Livio AI is also the first hearing aid featuring Amazon Alexa connectivity.
Toronto, Ontario, Canada-based Titan Medical, a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIsS), has been granted U.S. Patent No. 10,058,396, "System and Apparatus for Insertion of an Instrument Into a Body Cavity for Performing a Surgical Procedure." The patent covers technology that advances the ease of use and positioning of robotic surgical systems, including single-port robotic surgical systems such as the company's SPORT Surgical System. The technology was developed internally at Titan and was led by Dr. Perry Genova, the company's senior vice-president of R&D.